These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
10. Epidemiological study of severe cutaneous adverse drug reactions in a city district of China. Li LF; Ma C Clin Exp Dermatol; 2006 Sep; 31(5):642-7. PubMed ID: 16901302 [TBL] [Abstract][Full Text] [Related]
11. The prevalence of acute cutaneous drug reactions in a Scandinavian university hospital. Borch JE; Andersen KE; Bindslev-Jensen C Acta Derm Venereol; 2006; 86(6):518-22. PubMed ID: 17106599 [TBL] [Abstract][Full Text] [Related]
12. [Clostridium difficile infection in a Department of Internal Medicine. A consecutive series of 45 patients]. Bligny D; Cador B; Jolivet-Gougeon A; Le Strat A; Cazalets C; Laurat E; Jego P; Bouget J; Grosbois B Ann Med Interne (Paris); 2002 Sep; 153(5):291-9. PubMed ID: 12442074 [TBL] [Abstract][Full Text] [Related]
14. Risk of drug-related problems for various antibiotics in hospital: assessment by use of a novel method. Blix HS; Viktil KK; Moger TA; Reikvam A Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):834-41. PubMed ID: 18381745 [TBL] [Abstract][Full Text] [Related]
15. Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains. Urbánek K; Kolár M; Lovecková Y; Strojil J; Santavá L J Clin Pharm Ther; 2007 Aug; 32(4):403-8. PubMed ID: 17635342 [TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with extended-spectrum beta-lactamase-producing organisms at a tertiary care hospital. Graffunder EM; Preston KE; Evans AM; Venezia RA J Antimicrob Chemother; 2005 Jul; 56(1):139-45. PubMed ID: 15917283 [TBL] [Abstract][Full Text] [Related]
18. [Retrospective analysis of adverse cutaneous drug reactions in patients hospitalized in Department of Dermatology and Venereology of Pomeranian Medical University in 1996-2006]. Kacalak-Rzepka A; Klimowicz A; Bielecka-Grzela S; Załuga E; Maleszka R; Fabiańczyk H Ann Acad Med Stetin; 2008; 54(2):52-8. PubMed ID: 19374232 [TBL] [Abstract][Full Text] [Related]
19. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine. Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850 [TBL] [Abstract][Full Text] [Related]
20. [Side effects of the use of antibiotics. Hematological changes]. Dorantes S Gac Med Mex; 1976 May; 111(5):377-95. PubMed ID: 964531 [No Abstract] [Full Text] [Related] [Next] [New Search]